Go to Page # Page of 23

Bioanalytical Method Validation of the CK18 Apoptosis Biomarker for NASH Drug Development

 Sumit Kar
  13th-Sep-2018
Description: Bioanalytical Method Validation of the CK18 Apoptosis Biomarker for NASH Drug Development.
Views: 1748
Domain: Medical
Category: Biotech/Pharma
Contributing Organization: VIROLOGY EDUCATION
 ‐ More of their Presentations
Contents:
A Context of Use Framework for Bioanalytical
Method Validation of the CK18 Apoptosis
Biomarker for NASH Drug Development
Sumit Kar
Lead Scientist, Biomarkers
NASH Biomarkers Workshop 2018

NASH and Soluble Biomarkers
▪ “Liquid biopsy”
▪ Pathophysiological concentrations of
hormones, cytokines or metabolites
related to fatty liver disease

▪ Clinical biomarkers
... See more

Recent Presentations

P. Le Du
15 November, 2018

Research on Stem Cells The Conference 2018

Research on stem cells conference 2018 will help you know more about stem cells building blocks. it has the remarkable potential to develop into many several cell types.

...
14 November, 2018
...
13 November, 2018